U.S. Interactive Media and Services Stock News

NasdaqGS:CHA
NasdaqGS:CHAHospitality

Chagee Holdings (CHA) Launches Its First Matcha Collection And Expands Seasonal Drinks

Chagee Holdings (NasdaqGS:CHA) has launched its first proprietary matcha beverage collection, built around a premium Chinese matcha blend from select cultivars. The company has also expanded its seasonal lineup with Citrus Teafresher drinks that emphasize tea-forward, refreshing flavor profiles. The new offerings highlight Chagee Holdings' focus on premium sourcing, craftsmanship, and a modern teahouse experience. For investors tracking Chagee Holdings at a share price of $11.48, this...
NYSE:BMNR
NYSE:BMNRSoftware

Bitmine Immersion Technologies (BMNR) Nears Russell 1000 Entry And Co Founds Ethlabs

Bitmine Immersion Technologies (NYSE:BMNR) is approaching inclusion in the Russell 1000 index, which would trigger buying by index-tracking funds once finalized. The company has co founded Ethlabs, a new nonprofit research lab focused on Ethereum, with the goal of supporting institutional use of the network. Bitmine Immersion Technologies operates in the crypto infrastructure space, where institutional interest in digital assets and blockchain tooling continues to evolve. Potential...
NYSE:CCL
NYSE:CCLHospitality

Carnival (CCL) Stock After Recent Run Is There Still Value On Offer

If you are wondering whether Carnival stock is still priced attractively after its recent run, the current setup makes the valuation story worth a closer look. The share price closed at US$28.72, with returns that declined 7.1% over the last week, rose 10.5% over the last month, declined 7.1% year to date, and gained 13.0% over the last year, as well as 82.7% over three years and 12.6% over five years. Recent coverage has focused on Carnival’s ongoing recovery in travel demand and investor...
NYSE:FITB
NYSE:FITBBanks

3 US Bank Stocks With Growth and Dividends Under Fresh Fed Scrutiny

The death of former Federal Reserve Chairman Alan Greenspan has pushed old debates about interest rates, deregulation, and financial stability back to center stage, and that matters directly for US financial sector stocks. When investors reexamine the Fed’s role in credit growth, labor power, and risk-taking, certain banks and insurance companies can look either more appealing or more exposed, depending on their business models and balance sheets. This article looks at three US financial...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

3 Reasons CSX (CSX) Looks Fully Priced Despite Strong Recent Momentum

How CSX Stock Has Been Performing Recently CSX (CSX) has drawn investor attention after a period of mixed short term returns, with the stock roughly flat over the past day, lower over the past week, yet positive over the past month and past 3 months. See our latest analysis for CSX. At a share price of US$46.16, CSX has seen short term share price momentum ease slightly. However, the 90 day share price return of 16.65% and 1 year total shareholder return of 44.13% point to stronger...
NYSE:KMI
NYSE:KMIOil and Gas

Does Kinder Morgan’s Data Center-Fueled Backlog Strengthen the Cash Flow Story for KMI?

Earlier in 2026, Barclays reaffirmed its positive rating on Kinder Morgan after the company reported strong quarterly results and a US$10.10 billion project backlog that now includes several data center-related contracts. An interesting angle for investors is how this enlarged backlog, combined with expectations for higher adjusted earnings and EBITDA, reinforces Kinder Morgan’s case for durable, contract-based cash flows and ongoing dividend support. We’ll now examine how Kinder Morgan’s...
NYSE:DINO
NYSE:DINOOil and Gas

Earnings-Driven Zacks Upgrade and Q2 2026 Results Might Change The Case For Investing In HF Sinclair (DINO)

HF Sinclair was recently upgraded to a Zacks Rank #2 (Buy) on the back of higher earnings estimates, and in July 2026 it released its Q2 2026 results alongside a webcast discussing performance across its refining and global lubricants operations. The analyst upgrade, rooted in improving earnings expectations, highlights how changes in forecast profitability can meaningfully influence how investors view HF Sinclair’s future prospects. Next, we’ll examine how the Zacks earnings-driven upgrade...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Is Southern Copper (SCCO) Fully Priced On Its Production Beat And $20.5b Expansion Plan?

Southern Copper (SCCO) is back in focus after the company said it exceeded its 2026 copper production targets and outlined a decade-long expansion program in Peru and Mexico totaling more than US$20.5 billion. See our latest analysis for Southern Copper. The share price has pulled back recently, with a 1-day share price return of 5.97% and a 7-day share price return of 8.20%. However, the year to date share price return of 22.33% and 1-year total shareholder return of 95.99% point to strong...
NYSE:SGOV
NYSE:SGOVCapital Markets

US Treasury Bond ETFs Back In Focus As Fed Signals Higher Rates

With the US Federal Reserve under Kevin Warsh signaling a more hawkish stance and bond yields reacting, short term US Treasury and government bond ETFs are back in focus for investors weighing risk and income. As markets adjust to the prospect of rate hikes and a smaller, less interventionist central bank, some stocks exposed to this news may appear better positioned than others. This article walks through three positively exposed stocks from the Short-Term US Treasury and Government Bond...
NasdaqCM:ALMU
NasdaqCM:ALMUSemiconductor

Aeluma (ALMU) Pulled Back After Strong Gains, Is The Stock Overvalued?

Aeluma stock: recent moves in context Aeluma (ALMU) shares have seen mixed recent performance, with the stock down 6.4% on the day and 7.5% over the past week, while still up over the past 3 months and year to date. For investors tracking shorter term swings alongside longer term performance, these moves raise questions about how current pricing lines up with Aeluma’s revenue of US$5.196 million and its reported net loss of US$6.004 million. See our latest analysis for Aeluma. At a share...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Do Intuitive Surgical’s (ISRG) New Commercial Leaders Reframe Its Resilience Amid FDA Scrutiny?

In late May, Intuitive Surgical announced that long-time executive Taylor Patton would become Chief Commercial and Marketing Officer from July 1, while former CCMO Henry Charlton moved to a new Senior Vice President of Global Business Operations role to support value generation and continuity. These leadership shifts occurred as the company managed FDA safety alerts, product recalls, and rising competition in robotic-assisted surgery, putting its recurring revenue model and installed base...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Signs Abbisko Deal To Add New Drug Targets

Eli Lilly (NYSE:LLY) has entered a new multi-target research and license agreement with Abbisko Therapeutics. The partnership focuses on early-stage discovery programs and access to new therapeutic targets. The deal includes multiple potential drug candidates and substantial milestone opportunities. Eli Lilly is expanding its reach in biopharmaceutical research through this agreement with Abbisko, adding more early-stage programs to its pipeline. For you as an investor, this points to a...
NYSE:MUR
NYSE:MUROil and Gas

Should Murphy Oil’s New Bubale-1X Offshore Discovery Reshape the Risk-Reward View for MUR Investors?

Murphy Oil Corporation recently reported an oil discovery at the Bubale-1X exploration well in Block CI-709 offshore Côte d’Ivoire, where the late-February-spud well encountered 100 feet of net oil pay across two reservoirs containing high-quality light oil. The find, made with Murphy holding a 90% working interest alongside state oil company PETROCI, closes its current three-well campaign and moves the block into an appraisal phase that could materially influence future development plans...
NYSE:DCH
NYSE:DCHAuto Components

Dauch (DCH) Faces An Undervaluation Debate, Is The Weakness A Buying Opportunity?

Dauch (DCH) has attracted investor attention after a period of share price weakness, with the stock down 8% over the past week and 12% over the past month from its recent close. See our latest analysis for Dauch. Looking beyond this recent weakness, Dauch’s 1-year total shareholder return of 35.89% contrasts with its year to date share price decline of 12.48%. This suggests momentum has cooled following a stronger prior period. If you want to see what else is moving around Dauch’s part of the...
NYSE:UGI
NYSE:UGIGas Utilities

Is UGI (UGI) Undervalued After Its Pennsylvania Rate Case Narrative?

Recent Performance Snapshot for UGI Stock UGI (UGI) has drawn attention after a mixed period for its stock, with the price recently closing at $34.72. Short term returns were positive, although the share price was down over the past month and over the past three months. See our latest analysis for UGI. Looking beyond the latest move, UGI stock shows short term share price momentum that has recently softened, with the year to date share price return down 7.73% while the 3 year total...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Lumentum (LITE) Reveals $400 Million AI Optics Backlog And Data Center Partnerships

Lumentum Holdings (NasdaqGS:LITE) highlighted an AI-focused optics backlog exceeding $400 million at a recent global conference on AI ethics and governance. Leadership outlined how optical circuit switches and co packaged optics are positioned within AI data center infrastructure build outs. The company also discussed AI data center partnerships, emphasizing collaboration with large scale customers and ecosystem players. These comments add fresh detail on Lumentum Holdings' role in AI...
NasdaqGM:DJT
NasdaqGM:DJTInteractive Media and Services

Does Truth Social’s God Bless America ETF Relaunch Reshape the Fintech Ambitions of Trump Media (DJT)?

Yorkville America Equities LLC, sponsor and investment adviser for the Truth Social Funds, recently relaunched the Truth Social God Bless America ETF (ticker: YALL), which sits within Trump Media & Technology Group’s Truth.Fi fintech brand and continues to be managed by founder Adam Curran of Curran Financial Partners under an America-First investment thesis. This relaunch highlights Trump Media & Technology Group’s push to build out a broader financial products ecosystem tied to its Truth...
NYSE:HIMS
NYSE:HIMSHealthcare

Hims & Hers Health (HIMS) Expands GLP 1 Reach, Is The Upside Already Priced In?

Hims & Hers Health (HIMS) is back in focus as investors weigh its expanding GLP-1 weight-loss offering, its new partnership with Novo Nordisk, and the international acquisition of Eucalyptus. See our latest analysis for Hims & Hers Health. Hims & Hers Health shares trade at US$32.96 after a strong recent run, with a 30 day share price return of 38.78% and a 90 day share price return of 58.16%, while the 1 year total shareholder return is down 23.26% but the 3 year total shareholder return is...
NYSE:FDX
NYSE:FDXLogistics

FedEx (FDX) Is Down 5.5% After Post-Spin Q4 Beat But Softer 2026 EPS Guidance – Has The Bull Case Changed?

FedEx reported its fiscal fourth-quarter and full-year 2026 results, with Q4 revenue rising to US$25,007 million while net income slipped to US$1,598 million, and full-year revenue increasing to US$94,720 million alongside higher annual earnings per share from continuing operations of US$18.55. The company also completed the spin-off of FedEx Freight, raised its annual dividend by 5%, and issued new guidance calling for around 11% revenue growth and diluted EPS of US$16.55 to US$17.75 for...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

The Bull Case For Bio-Techne (TECH) Could Change Following Renewed Analyst Support In A Soft Market

On 23 June 2026, TD Cowen analyst Kyle Boucher reiterated a positive view on Bio-Techne, describing it as a premier small to mid-cap option despite ongoing life sciences market softness and recent insider selling. His comments, alongside a broader consensus that still sees moderate upside for the company despite funding and demand headwinds, suggest investors are reassessing how Bio-Techne is valued within a challenged sector. Next, we'll examine how this renewed analyst confidence, despite...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

Is BridgeBio Pharma (BBIO) Undervalued As Rare Disease Launch Hopes Face A Rich P/S?

BridgeBio Pharma stock performance snapshot BridgeBio Pharma (BBIO) trades at $68.63 after a mixed recent performance, with gains over the past week but declines over the month and past 3 months, while its 1 year total return remains positive. Investors watching BridgeBio Pharma may also note annual revenue of $579.96 million alongside a reported net loss of $721.55 million. This highlights an active development pipeline that is not yet translating into positive earnings. See our latest...
NYSE:INFQ
NYSE:INFQTech

Infleqtion (INFQ) Rebounds Sharply, Is The Stock Still Cheap?

Infleqtion stock moves after recent performance swing Infleqtion (INFQ) has drawn attention after a sharp move in its stock, with a 12.3% gain over the past day and a 19.3% rise across the past week prompting closer investor scrutiny. See our latest analysis for Infleqtion. Set against a year-to-date share price return that is down 6.9%, the recent 40.9% 90-day share price return suggests momentum in Infleqtion is building again as investors reassess its quantum computing potential and risk...
NYSE:FNB
NYSE:FNBBanks

F.N.B (FNB) Gains Ground On Digital Growth Hopes, Is It Still Trading At A Discount?

F.N.B (FNB) has drawn investor attention after recent share price moves, with the stock closing at US$18.75. That puts the regional bank's market value at around US$6.5b. See our latest analysis for F.N.B. Recent trading has added to a relatively steady upswing for F.N.B, with a 1 day share price return of 2.12% and a 90 day share price return of 13.71%, alongside a 1 year total shareholder return of 34.32% that points to momentum building over a longer horizon. If F.N.B has you looking more...
NasdaqGS:MAR
NasdaqGS:MARHospitality

How AI, Wellness, and Luxury Expansion At Marriott (MAR) Has Changed Its Investment Story

In recent weeks, Marriott International has rolled out its Ask Bonvoy conversational AI search in beta, opened its 10,000th property, the JW Marriott Ranthambore Resort & Spa in India, and entered a joint venture to bring luxury wellness brand Lefay into its global portfolio. These moves highlight how Marriott is pairing large-scale global expansion with proprietary AI, wellness, and lifestyle offerings to deepen loyalty and differentiate its hotel network. We’ll now examine how the Ask...